Prostatis Group’s State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF SPTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-92,976
Closed -$93K 219
2023
Q2
$93K Buy
+92,976
New +$4.8M 0.04% 140
2022
Q2
Sell
-5,043
Closed -$280K 79
2022
Q1
$280K Sell
5,043
-6,952
-58% -$381K 0.22% 63
2021
Q4
$701K Sell
11,995
-3,623
-23% -$205K 0.43% 41
2021
Q3
$828K Sell
15,618
-647
-4% -$35.2K 0.49% 45
2021
Q2
$862K Sell
16,265
-1,145
-7% -$59.2K 0.59% 43
2021
Q1
$856K Sell
17,410
-2,158
-11% -$103K 0.67% 32
2020
Q4
$902K Sell
19,568
-9,682
-33% -$422K 0.76% 28
2020
Q3
$1.2M Buy
29,250
+12,042
+70% +$488K 1.13% 24
2020
Q2
$650K Buy
17,208
+8,751
+103% +$313K 1.31% 26
2020
Q1
$266K Sell
8,457
-17,495
-67% -$658K 0.38% 36
2019
Q4
$1.03M Buy
+25,952
New +$989K 0.93% 29

Other funds holding SPTM

Prostatis Group's SPTM Position: Q3 2023 in Review

Prostatis Group sold out of State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF (SPTM) in Q3 2023, closing a stake of 92,976 shares — an estimated $93K sold.

Prostatis Group first reported a position in SPTM in Q4 2019 and held it in 11 quarters. The position peaked at $1.2M in Q3 2020. 507 funds tracked by Wall St. Rank hold SPTM as of Q3 2023.

  • Prostatis Group reported no remaining State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 92,976 State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF shares in Q3 2023, an estimated $93K.
  • Prostatis Group first reported a position in State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q4 2019 and held it in 11 quarters.
  • Prostatis Group's State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF position peaked at $1.2M in Q3 2020.
  • 507 funds tracked by Wall St. Rank held State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.